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Objective: Hyperoxic cardiopulmonary bypass is widely used during cardiac
operations in the adult. This management may cause oxygenation injury
induced by oxygen-derived free radicals and nitric oxide. Oxidative damage
may be significantly limited by maintaining a more physiologic oxygen
tension strategy (normoxic cardiopulmonary bypass). Methods: During
elective coronary artery bypass grafting, 40 consecutive patients underwent
either hyperoxic (oxygen tension 5 400 mm Hg) or normoxic (oxygen
tension 5 140 mm Hg) cardiopulmonary bypass. At the beginning and the
end of bypass this study assessed polymorphonuclear leukocyte elastase,
nitrate, creatine kinase, and lactic dehydrogenase, antioxidant levels, and
malondialdehyde in coronary sinus blood. Cardiac index was measured
before and after cardiopulmonary bypass. Results: There was no difference
between groups with regard to age, sex, severity of disease, ejection fraction,
number of grafts, duration of cardiopulmonary bypass, or ischemic time.
Hyperoxic bypass resulted in higher levels of polymorphonuclear leukocyte
elastase (377 6 34 vs 171 6 32 ng/ml, p 5 0.0001), creatine kinase 672 6
130 vs 293 6 21 U/L, p 5 0.002), lactic dehydrogenase (553 6 48 vs 301 6
12 U/L, p 5 0.003), antioxidants (1.97 6 0.10 vs 1.41 6 0.11 mmol/L, p 5
0.01), malondialdehyde (1.36 6 0.1 mmol/L, p 5 0.005), and nitrate (19.3 6
2.9 vs 10.1 6 2.1 mmol/L, p 5 0.002), as well as reduction in lung vital
capacity (66% 6 2% vs 81% 6 1%, p 5 0.01) and forced 1-second expiratory
volume (63% 6 10% vs 93% 6 4%, p 5 0.005) compared with normoxic
management. Cardiac index after cardiopulmonary bypass at low filling
pressure was similar between groups (3.1 6 0.2 vs 3.3 6 0.3 L/min per
square meter). [Data are mean 6 standard error (analysis of variance),
with p values compared with an oxygen tension of 400 mm Hg.] Conclusions:
Hyperoxic cardiopulmonary bypass during cardiac operations in adults
results in oxidative myocardial damage related to oxygen-derived free
radicals and nitric oxide. These adverse effects can be markedly limited by
reduced oxygen tension management. The concept of normoxic cardiopul-
monary bypass may be applied to surgical advantage during cardiac
operations. (J Thorac Cardiovasc Surg 1998;116:327-34)
During surgical interventions of the normoxicadult heart, cardiopulmonary bypass (CPB) is
commonly instituted in a hyperoxic fashion (oxy-
gen tension [PO2] 300 to 400 mm Hg) without
considering the toxic potentials of high levels of
molecular oxygen. Our previous studies have dem-
onstrated that hyperoxic CPB may lead to a
myocardial reoxygenation injury in hypoxic imma-
ture hearts.1, 2 The relevance of these findings is
reinforced by clinical reports showing myocardial
lipid peroxidation in preischemic myocardial bi-
opsy samples from cyanotic children3 and myocar-
dial dysfunction in hypoxic infants undergoing
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extracorporeal membrane oxygenation without
surgical ischemia.4
Oxygen-derived free radicals and nitric oxide
(NO)-derived peroxinitrite play an important role in
the development of hyperoxic damage.5, 6 This as-
sumption is partly based on the beneficial effect of
treatment with oxygen-derived free radical scaven-
gers7, 8 and by direct evidence of increased levels of
oxygen-derived free radicals during reoxygenation.9
The rate of production of these highly reactive toxic
oxygen species is dependent on the oxygen level
during reoxygenation and on cellular oxygen metab-
olism.10, 11 In their early studies, Hearse, Humphrey,
and Bullock12 could demonstrate that lowering PO2
during reoxygenation was followed by less release of
myocardial creatine kinase.12 Further investigations
found similar results in organs other than the
heart.11, 13 We14 introduced the concept of normoxic
CPB in hypoxemic immature hearts to avoid myo-
cardial damage after hyperoxia. The present clinical
study of normoxic adult hearts supported by CPB
tests the hypothesis that reduction of oxygen con-
centration in the circuit of the extracorporeal circu-
lation to normoxic levels can reduce the damaging
effects of hyperoxia and will result in an improved
postoperative myocardial status.
Patients and methods
Patients. Included in the study were 40 consecutive
patients scheduled for elective coronary artery bypass
grafting between July and October of 1996 and operated
on by the same surgeon. They were randomized to
encounter either hyperoxic (PO2 5 400 mm Hg) or
normoxic (PO2 5 140 mm Hg) CPB, with the surgeon and
the intensive care unit staff blinded to the assignment. The
study was approved by the ethics committee of the
Johann-Wolfgang-Goethe University, Frankfurt, Ger-
many. Informed consent was obtained from patients be-
fore they were included in the study.
CPB and myocardial protection. After induction of
general anesthesia and systemic application of heparin
(300 IU/kg body weight), CPB (Sto¨ckert Instrumente,
Mu¨nchen, Germany) was initiated in a standard fashion.
Moderate body hypothermia (28° to 32° C) was used. The
coronary sinus was cannulated (Research Medical Inc.,
Salt Lake City, Utah) and antegrade/retrograde blood
cardioplegic arrest was used in all patients as described
elsewhere.15 One group of patients underwent hyperoxic
CPB (PO2 5 400 mm Hg) (normal clinical practice) and
the other group underwent normoxic CPB (PO2 5 140 mm
Hg). Arterial oxygen levels were measured by means of an
in-line oxygen determination device (Extracorporeal
Blood Gas Monitoring System 300, Cardiovascular De-
vices Inc., Irvine, Calif.). Other than the oxygen content
during CPB, the patient management was the same for
both groups. After the patients had been rewarmed to a
core temperature of at least 35° C, CPB was discontinued
and protamine given for heparin reversal.
Blood samples and measurements. Samples of coro-
nary sinus blood (for determination of polymorphonu-
clear leukocyte [PMN] elastase, creatine kinase, lactic
dehydrogenase, antioxidant levels, malondialdehyde, ni-
trate, and glucose) and systemic venous blood (for lactate,
pH, PO2, and PCO2) were taken at the beginning and at the
end of CPB. PMN elastase was measured by means of an
immunoassay (Merck, Darmstadt, Germany). Creatine
kinase, lactic dehydrogenase, lactate, and glucose deter-
minations were done by means of test kits (Boehringer
Fig. 1. PMN elastase in coronary sinus blood at the start
and end of CPB in comparison of patients undergoing
hyperoxic (PO2 5 400 mm Hg) or normoxic (PO2 5 140
mm Hg) CPB.
Table I. Clinical characteristics and intraoperative
and postoperative data of the patient groups
undergoing either hyperoxic or normoxic CPB
Hyperoxic Normoxic p Value
No. of patients 20 20
Male 16 17
Female 4 3
Inotropic support (No.) 4 2
Smokers (No.) 14 12
Diabetes mellitus (No.) 5 7
Age (yr) 61 6 2 63 6 2 0.4
Ejection fraction (%) 61 6 5 61 6 6 0.9
PO2 on CPB (mm Hg) 419 6 13 142 6 9 0.0001
No. of grafts 3 6 0.1 3 6 0.1 0.9
CPB time (min) 82 6 4 81 6 3 0.9
Ischemic time (min) 53 6 2 52 6 2 0.6
Ventilator support (hr) 22 6 8 14 6 1 0.2
Days in ICU 1.9 6 0.1 1.6 6 0.2 0.08
Days in hospital 9.6 6 0.5 8.6 6 0.3 0.06
CPB, Cardiopulmonary bypass; PO2 , oxygen tension; ICU, intensive care
unit.
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Mannheim GmbH, Mannheim, Germany). Blood antiox-
idant status was determined according to the method of
Miller and colleagues.16 This test measures the total
plasma antioxidant activity without differentiating be-
tween individual contribution of plasma antioxidants (i.e.,
ascorbate, protein thiols, bilirubin, urate, and a-toco-
pherol).16 Malondialdehyde was determined by the
method described by Wong and coauthors.17 Nitrate was
measured after reduction to nitrite as described by Green
and colleagues.18
Cardiopulmonary measurements. A Swan-Ganz pul-
monary artery catheter (Baxter Healthcare Corp., Ed-
wards Division, Santa Ana, Calif.) was inserted for mea-
surement of pulmonary artery and pulmonary capillary
wedge pressure and for measurement of cardiac output.
Hemodynamic measurements were made before starting
the surgical procedure and after skin closure. Cardiac
index (L/min/m2) is cardiac output (L/min) divided by
body surface area (m2). Pulmonary vascular resistance
index (PVRI) was calculated by means of the following
equation: PVRI (mm Hg 3 min 3 L–1 3 kg) 5 (PAP –
LAP) (mm Hg) 3 CO–1 (ml/min) 3 BW (kg), where PAP
is pulmonary artery pressure, LAP is left atrial pressure,
CO is cardiac output, and BW is body weight.
Pulmonary function tests were done 1 day before and 5
days after the operation. Measurements included vital
capacity, forced vital capacity, forced expiratory volume in
the first second, and maximum expiratory flow at 50%
vital capacity. The results are given as percent of normal
values, corrected for sex, age, and body surface area.
Statistical analysis. Statistical analysis was done in
cooperation with the Statistical Department of the Albert-
Ludwigs-University Freiburg, Germany. Data were ana-
lyzed with StatView V2.0 on an Apple Macintosh IICi
computer. Analysis of variance was used for overall com-
parison. Differences between individual groups were eval-
uated by t test and Scheffe F test. The end-CPB values
were used unless stated otherwise. The paired two-tailed
Student’s t test was used for comparison of repeatedly
documented variables within experimental groups. Group
data are expressed as mean 6 standard deviation.
Results
General. The groups did not differ in terms of
age, sex, severity of disease, comorbidity, ejection
fraction, number of grafts, duration of CPB or
ischemia, and days in the intensive care unit. The
hospital stay of the hyperoxic group averaged 1 day
longer than that of the normoxic group (p 5 0.06).
The hyperoxic patients needed 57% longer duration
of ventilator support, but due to the larger standard
deviation this did not reach a statistically significant
level (p 5 0.2). The absolute values are displayed in
Table I. Values of calcium potassium, sodium, he-
matocrit, hemoglobin, erythrocytes, leukocytes, and
thrombocytes showed no differences between
groups (data not shown). The oxygen level in the
extracorporeal circulation was 419 6 13 mm Hg in
the hyperoxic group and 142 6 9 mm Hg in nor-
moxic patients (p 5 0.0001 vs hyperoxic).
Biochemical. PMN elastase increased 67-fold
(hyperoxic) and 55-fold (normoxic) at the end of
CPB compared with start-CPB values (p 5 0.0001).
End-CPB values were higher in the hyperoxic group
(p 5 0.0001 vs normoxic). The absolute values are
shown in Fig. 1.
Fig. 2. Creatine kinase in coronary sinus blood at the
start and end of CPB in comparison of patients undergo-
ing hyperoxic (PO2 5 400 mm Hg) or normoxic (PO2 5
140 mm Hg) CPB.
Fig. 3. Lactic dehydrogenase in coronary sinus blood at
the start and end of CPB in comparison of patients
undergoing hyperoxic (PO2 5 400 mm Hg) or normoxic
(PO2 5 140 mm Hg) CPB.
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Creatine kinase increased 25-fold (hyperoxic) and
12-fold (normoxic) at the end of CPB compared
with start-CPB values (p 5 0.0001 and 0.0002).
End-CPB values were higher in the hyperoxic group
(p 5 0.002 vs normoxic). The absolute values are
shown in Fig. 2.
Lactic dehydrogenase increased 570% (hyper-
oxic) and 331% (normoxic) at the end of CPB
compared with start-CPB values (p 5 0.0001). Pa-
tients in the hyperoxic group had higher values (p 5
0.003 vs normoxic). The absolute values are shown
in Fig. 3.
Levels of antioxidants increased 97% (hyperoxic;
p 5 0.0001) and 48% (normoxic; p 5 0.06) at the
end of CPB compared with start-CPB values. Pa-
tients in the hyperoxic group had higher values (p 5
0.01 vs normoxic). The absolute values are shown in
Fig. 4.
Malondialdehyde increased 1.3-fold (hyperoxic;
p 5 0.0001) and 0.5-fold (normoxic; p 5 0.08) after
CPB compared with start-CPB values. End-CPB
values were higher in the hyperoxic group (p 5 0.005
vs normoxic). The absolute values are shown in Fig.
5.
Nitrate was unchanged after CPB in the hyperoxic
group but was reduced in normoxic patients (p 5
0.002 vs pre-CPB and vs hyperoxic). The absolute
values are shown in Fig. 6.
Glucose levels after CPB were significantly in-
creased at the end of CPB (117 6 6 vs 251 6 9 mg/dl
[hyperoxic], 134 6 9 vs 289 6 11 mg/dl [normoxic];
p 5 0.0001 vs start-CPB). The normoxic patients
had higher values at the end of CPB (p 5 0.005 vs
hyperoxic).
Systemic venous levels of lactate, pH, PO2, and
PCO2 at the end of CPB showed no difference
between groups. The absolute values are shown in
Table II.
Cardiopulmonary values. Cardiac output mea-
sured at a left atrial pressure of 5 to 7 mm Hg
increased in both groups after CPB in comparison
with the pre-CPB values (p 5 0.06 and 0.06).
Although there was a tendency toward higher post-
CPB values in normoxic patients (6.5 6 0.6 vs 5.7 6
0.5 L/min), there was no difference between groups
(p 5 0.1). Cardiac index (L/min/m2) before and after
CPB was similar between groups (p 5 0.7 and 0.6).
The absolute values are shown in Fig. 7.
Vital capacity before CPB was the same in both
groups. In both groups it was lower after CPB than
before CPB. Normoxic patients had better vital
capacity after CPB than the hyperoxic group (p 5
0.008). Forced vital capacity before CPB displayed
no differences between groups. After CPB there was
a reduction in both groups, with higher absolute
values in normoxic patients (p 5 0.02 vs hyperoxic).
Fig. 4. Level of antioxidants in coronary sinus blood at
the start and end of CPB in comparison of patients
undergoing hyperoxic (PO2 5 400 mm Hg) or normoxic
(PO2 5 140 mm Hg) CPB.
Fig. 5. Malondialdehyde in coronary sinus blood at the
start and end of CPB in comparison of patients undergo-
ing hyperoxic (PO2 5 400 mm Hg) or normoxic (PO2 5
140 mm Hg) CPB.
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The 1% vital capacity was severely decreased after
hyperoxic CPB (p 5 0.0001 vs pre-CPB and p 5
0.005 vs normoxic CPB).
Maximal expiratory flow also was reduced in pa-
tients undergoing hyperoxic CPB (p 5 0.0001 vs before
CPB) and displayed no changes in normoxic patients
(p 5 0.8 and p 5 0.003 vs hyperoxic patients). The
absolute values are displayed in Table III.
Pulmonary vascular resistance was reduced after
CPB in both groups (p 5 0.2 and 0.08). There was
no significant difference between groups. The abso-
lute values are displayed in Table III.
Discussion
Hyperoxic CPB is widely used during surgical
repair of hypoxic immature and normoxic adult
hearts. The results of the current study indicate that
this practice may expose the heart to oxidative
damage resulting in enzyme release and lipid per-
oxidation. The observed hyperoxic oxygenation in-
jury in normoxic adult hearts is similar to the
reoxygenation injury of hypoxic immature hearts
supported by CPB.1, 2, 14 The damaging potential of
hyperoxic CPB can be limited markedly by reduced
PO2 management (normoxic reoxygenation). This
new strategy of normoxic CPB may be used to
surgical advantage during cardiac operations in both
children and adults.
A widely known example of the damaging effect
of hyperoxia is retrolental fibroplasia in premature
infants treated with high oxygen levels during ven-
tilator support.19 Previous studies of the hypoxic
immature heart suggested the existence of the dam-
aging potential of high oxygen levels during extra-
corporeal circulation.1, 2, 14 Support for these find-
ings stems from clinical studies of cyanotic children
with tetralogy of Fallot having lipid peroxidation
after the start of CPB.3 Additionally, there is evi-
dence of myocardial dysfunction in infants in whom
extracorporeal membrane oxygenation is used, de-
spite absence of surgical ischemia.4 Despite the
known damaging potential of high oxygen levels,
CPB is commonly constituted in a hyperoxic fashion.
And although several adverse effects of CPB (i.e.,
complement activation, release of PMN elastase and
tumor necrosis factor, oxygen-derived free radical
production) have already been addressed, the influ-
ence of hyperoxia during extracorporeal circulation
has yet to be established.20, 21 CPB itself can lead to
the production of damaging oxygen-derived free
radicals.20 Highly cytotoxic reduced oxygen species
(O2
2, H2O2 and zOH) play a central part in oxygen-
mediated injury.5 During normal metabolism, the
cell protects itself from these products by ubiquitous
endogenous free radical scavengers, which may be
depleted by severe stress (hypoxia, ischemia).
Thereafter, the burst of free radical production that
occurs with the onset of reoxygenation or hyperoxia
overwhelms the scavenging capacity of the reduced
cellular defense system.22 Support for this observa-
tion stems from direct evidence of these toxic oxy-
gen species with spin trapping and by avoiding
Fig. 6. Nitrate in coronary sinus blood at the start and
end of CPB in comparison of patients undergoing hyper-
oxic (PO2 5 400 mm Hg) or normoxic (PO2 5 140 mm Hg)
CPB.
Fig. 7. Cardiac index before and after CPB in compari-
son of patients undergoing hyperoxic (PO2 5 400 mm Hg)
or normoxic (PO2 5 140 mm Hg) CPB.
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oxygenation injury with antioxidants.9, 22 We8, 23
confirmed these observations recently by showing a
positive effect of cardioplegic enrichment, or prime
supplementation with antioxidants to reduce reoxy-
genation injury in hypoxic immature piglet hearts.
Instead of treatment with antioxidants, it is con-
ceivable that oxygen-derived free radicals can be
avoided by lowering PO2 during extracorporeal cir-
culation. The production of toxic oxygen species is
proportionate to PO2.
7, 11, 24 Hyperoxemia sharply
elevates the amount of oxygen dissolved in the
membrane lipid matrix, thereby enhancing the pos-
sibility of oxygen interaction with reduced electron
carriers and accentuating free radical production.24
In an experimental animal model without CPB,
Hearse, Humphrey, and Bullock12 have shown that
myocardial damage that occurs with reoxygenation
is highly depended on PO2 and that lowering oxygen
levels will result in reduced creatine kinase release.
It is conceivable that the reoxygenation injury be-
comes exaggerated when hypoxic myocardium is
exposed abruptly to high PO2, as occurs when CPB is
started.1 Similar to these observations, the results of
the present study suggest the existence of an oxy-
genation injury in normoxic adult hearts on CPB.
Compared with the start of CPB, there was a
significant increase in PMN elastase, creatine ki-
nase, lactic dehydrogenase, and malondialdehyde,
as well as reduced antioxidants at the end of the
extracorporeal circulation. In contrast, applying nor-
moxic CPB resulted in a significant improvement
within these parameters. It is speculated that further
reduction of PO2 during CPB (100 mm Hg) will lead
to further improvement in results. This hypothesis is
based on the observation that reoxygenation injury
is reducible by controlling oxygen levels in CPB
prime and blood cardioplegic solutions to 100 mm
Hg, to apply normoxia during the initial reoxygen-
ation period.14 Furthermore, for the first time, we
described a new method of “controlled reoxygen-
ation” in which CPB is started with ambient PO2 (30
mm Hg) and normoxic reoxygenation is begun at the
time of cardioplegic arrest.25 Applying this method,
we were able to avoid biochemical evidence of
reoxygenation injury and to present almost com-
plete functional recovery in previously hypoxic
hearts.2 These findings and the results of the current
study reinforce the hypothesis that oxygenation in-
jury is dependent on PO2 and confirm the salutary
effect of avoiding hyperoxia.
A second pathway of oxidant injury was proposed
by Beckman and associates,6 whereby superoxide
anion and NO interact to form cytotoxic oxygen
species. Furthermore, NO generation is dependent
on PO2 level.
26 In cyanotic immature hearts we
demonstrated a burst of NO at the onset of CPB
associated with oxidant damage and myocardial
dysfunction, which could be ameliorated by NO
inhibition.27 Additionally, lowering oxygen levels in
the circuit of the extracorporeal circulation and in
blood cardioplegic solution limited NO release.25 In
the present study, controlling the rate of introduc-
tion of molecular oxygen at the start of CPB reduced
NO levels when compared with unchanged high
values after hyperoxia. It is speculated that excess
NO reacts with oxygen and generates OONO2,
which then decomposes to generate highly toxic 02
and N2 intermediates that produce lipid peroxida-
tion. As in previous studies, reduced NO levels were
accompanied by impaired malondialdehyde (lipid
peroxidation), reduced creatine kinase release, and
preserved antioxidant reserve capacity.2, 14, 25 How-
ever, the role of NO in cardiac oxygenation injury on
CPB has to be addressed further. The present
clinical study was purely observational and was not
undertaken to investigate underlying mechanisms,
as is the aim of basic research.
The synergism of damage related to oxygen-
derived free radicals and neutrophil elastase has
been reported.28 We measured PMN elastase, which
Table II. Venous lactate, pH, PO2, and PCO2 levels at the beginning and the end of hyperoxic or normoxic
CPB
Hyperoxic Normoxic
p Value*Beginning End p Value Beginning End p Value
Lactate (mg/dl) 44.4 6 5.0 20.8 6 1.3 0.001 37.3 6 3.9 17.7 6 1.5 0.0001 0.3
pH 7.35 6 0.02 7.34 6 0.01 0.08 7.33 6 0.01 7.35 6 0.01 0.1 0.2
PO2 (mm Hg) 63 6 5 45 6 2 0.0001 59 6 2 43 6 4 0.0001 0.2
PCO2 (mm Hg) 43 6 1 46 6 2 0.08 46 6 1 47 6 1 0.6 0.8
CPB, cardiopulmonary bypass, normal range for lactate (9.6 to 17.1 mg/dl).
*Absolute values at the end of CPB in comparison between groups.
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was elevated after hyperoxic CPB, supporting
former reports in which, however, PO2 levels during
CPB are not mentioned.21 On the contrary, nor-
moxic CPB resulted in a significantly impaired in-
crease of PMN elastase, which was accompanied by
less lipid peroxidation and preserved antioxidant
levels. To our knowledge, this is the first time that a
PO2-dependent elastase release on CPB is described.
Oxygen-dependent reduction of lipid peroxidation
in this investigation confirms our previous findings,
as well as those of others.2, 7, 11, 14, 22, 23, 27
No significant difference between groups was
found in post-CPB contractility. However, cardiac
performance was measured at one low point of the
Starling function curve. It is speculated that apply-
ing more sensitive methods (conductance catheter)
or measuring cardiac performance at different pre-
load levels (Starling curves) may reveal impaired
function after hyperoxic CPB. This hypothesis is
based on our previous studies, in which severely
damaged hearts after reoxygenation injury could be
weaned from CPB without inotropic support and
had a normal cardiac output at low filling pressures.
However, measuring contractility with conductance
catheter or increasing stress by augmenting preload
suggested a severely impaired cardiac perfor-
mance.1, 2 In contrast, after normoxic or controlled
reoxygenation, these same measurements indicated
complete ventricular recovery.14, 25
We acknowledge that the results of the present
study are inconclusive in terms of cardiac perfor-
mance. However, even though short-term benefits
of normoxic CPB may not be immediately obvious,
long-term changes of lipid peroxidation and free
radical damage is currently unknown and will have
to be studied. However, there is no rationale to
expose patients to an obvious biochemical injury
whose long-term effect is yet to be determined and
which easily can be avoided by applying more phys-
iologic methods. We look to further clinical studies
using the described methods to prove whether bio-
chemical oxygenation injury in normoxic adult
hearts after hyperoxic CPB is accompanied by a
relevant loss in performance.
Impaired lung function in patients undergoing
hyperoxic CPB indicates that hyperoxia is not dam-
aging to the heart alone but rather has a whole body
effect, a theory that is supported by other re-
ports.13, 29 Leukocyte-originated oxygen free radi-
cal–related lipid peroxidation with subsequent lung
injury after CPB has been reported; unfortunately
the PO2 during CPB was not mentioned.
29 Leuko-
cyte depletion resulted in less injury.29 This finding
supports our observation that reduced leukocyte-
derived PMN elastase was associated with less lipid
peroxidation and creatine kinase release. Again,
further studies will clarify the effect of hyperoxia
during CPB on organs other than the heart.
Our former findings of a reoxygenation injury in
cyanotic immature hearts on hyperoxic CPB are
supported by the present clinical study, which for
the first time investigates the oxidative challenge of
hyperoxia during cardiac operations in adults, com-
paring it with a normoxic management.30 Former
findings of the damaging effect of CPB may be, at
least in part, more related to hyperoxia than to CPB
itself. We found convincing evidence that reduced
PO2 during CPB is crucial in avoiding oxygen-de-
rived free radical damage and lipid peroxidation.
Hyperoxia is not physiologic, it is damaging to all
organs, and it is not required during extracorporeal
circulation, where oxygen delivery can be adjusted
easily by augmenting pump flow. The safety of
normoxic CPB is confirmed by measurement of
venous lactate, pH, PO2, and PCO2, showing no
differences between groups. It is suggested that,
Table III. Pulmonary function 1 day before and 5 days after hyperoxic or normoxic CPB (pulmonary vascular
resistance is measured before and after CPB)
Hyperoxic Normoxic
p Value*Before After p Value Before After p Value
VC 98 6 6 66 6 2 0.0001 98 6 7 81 6 1 0.02 0.008
FVC 99 6 2 68 6 5 0.0001 98 6 4 83 6 4 0.02 0.02
FEV1 97 6 4 63 6 10 0.0001 98 6 6 93 6 4 0.3 0.005
MEF50 87 6 7 46 6 4 0.0001 88 6 9 82 6 12 0.8 0.03
PVRI 275 6 25 232 6 19 0.2 276 6 38 207 6 26 0.08 0.4
CPB, Cardiopulmonary bypass; VC, vital capacity (% norm); FVC, forced vital capacity (% norm); FEV1, forced expiratory volume during the first second
(% norm); MEF50 , maximum expiratory flow at 50% of VC (% norm); % norm, normal value of healthy individuals of equal sex, age, and body surface area;
PVRI, pulmonary vascular resistance index (mm Hg 3 min 3 L21 3 kg).
*Absolute values after CPB in comparison between groups.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 116, Number 2
Ihnken et al. 3 3 3
contrary to conventional practice, CPB in hypoxic
immature hearts as well as in normoxic adult hearts
is instituted in a normoxic fashion to avoid oxygen-
ation damage and lipid peroxidation.
We thank Dr. Olschewski, of the statistical department
of the Albert-Ludwigs-University Freiburg, for helping
with the statistical analysis.
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